
Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy
Keywords: تستوسترون; testosterone; prostatic neoplasms; androgen antagonists; castrationADT, androgen deprivation therapy; AIP, androgen independent progression; LH-RH, luteinizing hormone releasing hormone; mAb, maximal androgen blockade; PCa, prostate cancer; PSA, prostate